Pharma Excipients

News on Pharma Excipients

Fabrication of polymeric sorafenib coated chitosan and fucoidan nanoparticles: Investigation of anticancer activity and apoptosis in colorectal cancer cells

The most prevalent form of colon cancer also ranks high among cancer-related deaths globally. Traditional chemotherapy drugs do not provide sufficient therapeutic efficacy, and advanced colon cancer demonstrates considerable resistance to chemotherapy. As an oral kinase inhibitor, sorafenib (SOR) suppresses the growth of tumour cells, the formation…

28. May 2015 EXCIPACT-CERTIFICATION_UK-2015.pdf Adobe Acrobat Document 272.4 KB Download See also: https://www.pharmtech.com/view/colorcon-s-uk-site-adds-excipact-certification
Read More...